eli lilly pill glp 1 Oral GLP-1 Orforglipron Is Approved for Obesity Eli Lilly Weight-Loss Pill Shows

A retrospective, population-based cohort study found that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was safe and associated with lower risks of cardiovascular or psychiatric comorbidities and lower mortality among patients with psoriasis

The hypoglycemia risk deserves special attention, particularly for patients taking other diabetes medications

This pace reassures participants that results are achievable without dangerous shortcuts

Concurrently, the risk of MASLD is approximately 22.5 times higher in the PCOS populationa correlation that persists after adjusting for age and BMI (66, 119)positioning MASLD as the hepatic phenotype of systemic IR

The Three Tiers of Medicaid GLP-1 Coverage Understanding Medicaid GLP-1 coverage is easiest when you think of it in three tiers based on indication: Tier 1: Type 2 Diabetes Covered in All States (Required) Every state Medicaid program must cover GLP-1 medications when prescribed for Type 2 diabetes

Ozempic and Mounjaro are approved by the U.S